Co-ligation of the B cell receptor with complement receptor 2 (CR2/CD21) using its natural ligand C3dg: Activation without engagement of an inhibitory signaling pathway

被引：0
|
作者：
Lyubchenko, T
Dal Porto, J
Cambier, J
Holers, M
机构：
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
[2] Natl Jewish Med Res Ctr, Dept Immunol, Denver, CO 80206 USA
来源：
FASEB JOURNAL | 2005年 / 19卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A951 / A951
页数：1
相关论文
共 50 条
  • [41] Intracellular signaling pathways triggered by activation of the Epstein-Barr virus receptor (gp140, CR2, CD21, EBV/C3dR) on cell surface of human B lymphocytes
    Frade, Raymond
    Lottin, Severine
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [42] GP140, A C3B-BINDING MEMBRANE COMPONENT OF LYMPHOCYTES, IS THE B-CELL C3DG/C3D RECEPTOR (CR-2) AND IS DISTINCT FROM THE NEUTROPHIL C3DG RECEPTOR (CR4)
    FRADE, R
    MYONES, BL
    BAREL, M
    KRIKORIAN, L
    CHARRIAUT, C
    ROSS, GD
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1985, 15 (12) : 1192 - 1197
  • [43] Peripheral B cells hypo-responsive to antigenic challenge develop in transgenic mice that prematurely express complement receptor type 2 (CR2/CD21)
    Kulik, L
    Marchbank, KJ
    Haluszczak, C
    Morgan, P
    Holers, MV
    FASEB JOURNAL, 2003, 17 (07): : C95 - C95
  • [44] Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-β binding in B cells
    Cruickshank, Mark N.
    Fenwick, Emily
    Karimi, Mahdad
    Abraham, Lawrence J.
    Ulgiati, Daniela
    MOLECULAR IMMUNOLOGY, 2009, 46 (13) : 2613 - 2622
  • [45] Signaling through the Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) in human B lymphocytes: Activation of phosphatidylinositol 3-kinase via a CD19 independent pathway
    Bouillie, S
    Barel, M
    Frade, R
    MOLECULAR IMMUNOLOGY, 1998, 35 (6-7) : 350 - 350
  • [46] Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection
    1600, American Society for Biochemistry and Molecular Biology Inc., Bethesda, United States (265):
  • [47] Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice
    Twohig, Jason P.
    Pappworth, Isabel Y.
    Sivasankar, Baalasubramanian
    Kulik, Liudmila
    Bull, Melanie
    Holers, V. Michael
    Wang, Eddie C. Y.
    Marchbank, Kevin J.
    MOLECULAR IMMUNOLOGY, 2009, 46 (10) : 2002 - 2013
  • [48] Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes
    Leslie, RGQ
    Prodinger, WM
    Nielsen, CH
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (12) : 3311 - 3321
  • [49] Activation of the EBV/C3d receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase
    Barel, M
    Le Romancer, M
    Frade, R
    JOURNAL OF IMMUNOLOGY, 2001, 166 (05): : 3167 - 3173
  • [50] ANALYSIS OF EPSTEIN-BARR VIRUS-BINDING SITES ON COMPLEMENT RECEPTOR 2 (CR2/CD21) USING HUMAN-MOUSE CHIMERAS AND PEPTIDES - AT LEAST 2 DISTINCT SITES ARE NECESSARY FOR LIGAND-RECEPTOR INTERACTION
    MOLINA, H
    BRENNER, C
    JACOBI, S
    GORKA, J
    CAREL, JC
    KINOSHITA, T
    HOLERS, VM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (19) : 12173 - 12179
12345